By Jon Rappoport | No More Fake News | May 25, 2021 As I’ve been documenting for the past year, the COVID experts have been contradicting themselves six ways from Sunday. As charlatans, they’re abject failures. They can’t keep their own story straight. Thanks to an alert reader, I’ve come across a new blockbuster. BY […]
Brian Berletic | At every turn, industry cartels are undermining genuine alternatives to their corporate hegemony. It's time for ordinary people to play a direct role in helping expand to prevail over them.
New data from PHE suggests the vaccines are 90% effective in preventing symptomatic infection in the over 65s. But the study has numerous problems. It also shows the post-vaccine infection spike again.
Suzie Halewood Softening the electorate up to the prospect of inoculating all children over the age of 12, Secretary of State Control Matt Hancock says he has been ‘closely following the results from the clinical studies from Pfizer showing that the vaccine is safe and effective among children between the ages of 12 and 18’. …
21WIRE | How the US government helps Big Pharma capture new and emerging markets.
21WIRE | Some qualified scientists are finally beginning to challenge the omnipotence of the dominant drug firms.
21WIRE + Pub Med | A clear case of government and pharmaceutical industry collusion, and cartel-like corruption being wrought on a global scale - placing millions of lives at risk.
21WIRE | Will government regulators admit they were wrong to wave the normal drug regulatory process?
The vaccine rollout is set to extend to those below the age of 40 from Thursday, with the Pfizer and Moderna vaccines being offered as alternatives to that made by AstraZeneca "where possible".
The post Pfizer and Moderna Vaccines to Be Offered to Under-40s From Thursday appeared first on Lockdown Sceptics.
21WIRE | Evidence reveals how the US government has deprioritized treating sick patients, choosing instead to focus on the WHO recommended strategy of social distancing, lockdowns, masking and vaccines.
